Close

Reata Pharmaceuticals (RETA): Reiterating Rating And PT As CATALYST Trial Gets Off The Ground - Piper Jaffray

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. GM
2. SPY
3. TSLA
4. CPRI
5. NVDA
6. ADBE
7. VERX
8. RIL:IN
9. MTTR
10. TPR


Go back to Reata Pharmaceuticals (RETA): Reiterating Rating And PT As CATALYST Trial Gets Off The Ground - Piper Jaffray
(NASDAQ: RETA) Delayed: 172.36 --0 (-0%)
Previous Close $172.36    52 Week High $41.60 
Open $172.36    52 Week Low $11.03 
Day High $172.36    P/E N/A 
Day Low $172.36    EPS $0.00 
Volume 1